Searching for novel MDM2/MDMX dual inhibitors through a drug repurposing approach
AbstractDisruption of p53-MDM2/MDMX interaction by smaller inhibitors is a promising therapeutic intervention gaining tremendous interest. However, no MDM2/MDMX inhibitors have been marketed so far. Drug repurposing is a validated, practical approach to drug discovery. In this regard, we employed st...
Saved in:
Main Authors: | Keting Li (Author), Wenshu Hu (Author), Yingjie Wang (Author), Wenxing Chen (Author), Hongmei Wen (Author), Jian Liu (Author), Wei Li (Author), Bo Wang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design of ultrahigh-affinity and dual-specificity peptide antagonists of MDM2 and MDMX for P53 activation and tumor suppression
by: Xiang Li, et al.
Published: (2021) -
Controlling the Mdm2-Mdmx-p53 Circuit
by: David L. Waning, et al.
Published: (2010) -
Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen
by: Jiang-Jiang Qin, et al.
Published: (2017) -
Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
by: Biao Wang, et al.
Published: (2020) -
A small-molecule inhibitor of MDMX suppresses cervical cancer cells via the inhibition of E6-E6AP-p53 axis
by: Jingwen Zhang, et al.
Published: (2022)